The German pharmaceutical-and-agricultural group stated that the deal goals to enhance its ophthalmology pipeline.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Related Posts
Qualcomm announces AI chips to compete with AMD and Nvidia
Qualcomm introduced Monday that it’s going to launch new artificial intelligence accelerator chips, marking new competitors for Nvidia, which has…
Atlassian to Cut About 10% of Workforce, Cites Need to Adapt to AI
The corporate stated the cuts will permit it to speculate additional in AI and enterprise gross sales, in addition to…
My Friend Is Bad With Money and Won’t Take My Advice. What Do I Do?
Dear For Love & Money, My friend recently got divorced after 21 years of marriage. Her husband managed all the…